According to a recent market study published by Growth Market Reports, titled, “Global IVD Antibodies Market is segmented into by product, by application and by end-user and by Region: Size, Share, Trends and Opportunity Analysis, 2015-2030”, the market was valued at US$ 1,207.4 Million in 2021 and is expected to grow at a growth rate of 5.8 % by the year 2030.

In vitro diagnostics (IVD) are tests used for the detection and diagnosis of human diseases, infections, and other medical conditions. IVDs are done by diagnostic reagents using samples from blood or tissues. In vitro means 'in glass', meaning these tests are typically conducted in test tubes and similar glassware. Antibodies are proteins produced by plasma cells (a type of white blood cell) in response to an antigen. Antibodies act as a core reagent for a broad range of research and IVD applications. Polyclonal and monoclonal are widely used IVD antibodies.

Get Sample Report @ https://growthmarketreports.com/request-sample/5803

IVDs are a crucial part of modern medicine. These tests, performed on biological samples, provide key information for the prevention, treatment, and management of diseases. Currently, around two-thirds of all clinical diagnoses are performed with the help of IVD. These tests are not only used for diagnosis, but also for screening and monitoring diseases. IVD antibodies are commonly used for disease screening, therapeutic monitoring, and ensuring that the blood is safe for transfusions.

On the basis of product type, the global IVD Antibodies market is segregated into Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies, Bone Metabolism, Fertility and pregnancy care, Serology, Diabetes & Metabolism, Hormones, Infectious Diseases, Alzheimer’s disease, IHC, Tool Antibodies. The infectious disease segment is expected to hold a substantial share of the market during the forecast period, as they are widely used for detection of hepatitis, acquired immune deficiency syndrome (AIDS), tuberculosis, Covid-19, and others.

Based on application, the global IVD Antibodies market is classified into Immunology, Cancer, and cardiovascular diseases. The immunology segment is projected to expand at a significant CAGR during the forecast period, as it widely used by immunologist for clinical diagnostics and research applications due to their high specificity.

In terms of end user, the global IVD Antibodies market is segregated into hospitals, diagnostic laboratories, homecare settings, others. The hospital segment is projected to expand at a significant CAGR during the forecast period, due to the increase in diagnostic testing for detecting diseases and disorders such as kidney injury, diabetes, cardiovascular diseases, Alzheimer’s, and infections.

The outbreak of coronavirus disease in 2019 (COVID-19) had a moderately positive impact on the global IVD Antibodies market. The demand for IVD antibodies increased due to the widespread use of antibody tests to detect COVID-19 infection. This led to a shortage of IVD antibodies in some countries, as well as price increases for these products. Additionally, many IVD companies shifted their focus to developing and manufacturing COVID-19 antibody tests. This led to an increase in research and development spending and a rapid expansion of the market. The COVID-19 pandemic had a positive impact on the global IVD antibodies market.

As per growth market reports by industry analyst divyanka sankhe, “. IVDs are a crucial part of modern medicine. These tests, performed on biological samples, provide key information for the prevention, treatment, and management of diseases. These tests are not only used for diagnosis, but also for screening and monitoring diseases.

IVD antibodies are commonly used for disease screening, therapeutic monitoring, and ensuring that the blood is safe for transfusions. IVD antibodies are widely used for immunology methods such as ELISA, immunocytochemistry/immunofluorescence, immunohistochemistry, immunohistochemistry-paraffin, and western blot.

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. Raw materials used for manufacturing IVD Antibodies are shipped to manufacturers to be processed into final products. Quality checks are performed throughout the production process by manufacturers to ensure the quality of the product. Raw materials vary, depending upon the type of antibodies. Myeloma Cells and B-lymphocytes, Mouse or Rat, Culture Medium among others are utilized in the manufacturing of IVD Antibodies.

Key Takeaways from the Study:

The players in the global IVD Antibodies market include Abcam plc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Bio-Techne, GenScript, Creative Biolabs, Bio-Rad Laboratories, Inc, Rockland Immunochemicals Inc, HyTest Ltd, Leinco Technologies.

Report Metric

Details

Market Value in 2021

US$ 1,207.4 Million

Market Growth Rate (from 2022 to 2030)

5.8%

Historical Data

2015 - 2020

Base Year

2021

Forecast Period

2022 – 2030

Units Considered

Value (US$ Million)

Market Segments

By Product, By Application, By End User, By Region

Key Companies Profiled

Abcam plc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Bio-Techne, GenScript, Creative Biolabs, Bio-Rad Laboratories, Inc, Rockland Immunochemicals Inc, HyTest Ltd, Leinco Technologies

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

 

Target Audience:

  • Supply-side: Manufacturer and distributors.

  • Demand Side: Hospitals, Diagnostic Laboratories, Homecare Settings

  • Regulatory Side: Approved regulatory bodies.

  • Associations and Industry Bodies: USFDA and other regulatory bodies.